CDC grants for new infection strategies
This article was originally published in The Gray Sheet
The Centers for Disease Control and Prevention is soliciting grant proposals focusing, in part, on device and diagnostic interventions that would reduce hospital acquired infections in intensive care patients, central-line bloodstream infections, and the incidence of invasive methicillin-resistant staphylococcus aureus infections. CDC will award four grants worth up to $2 million each through its Prevention Epicenters Program, with a Sept. 30 deadline to apply. Catheter and catheter connector use, design and maintenance are among CDC's proposed areas of focus. At least one possible project would explore the effectiveness of various cleansing agents and techniques in reducing microbial contamination in catheter connectors and central venous catheters
You may also be interested in...
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.